Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 379,000 | -5,265,100 | -4,947,800 | -4,162,200 | -2,407,300 |
| Depreciation Amortization | 1,477,300 | 6,209,500 | 4,503,000 | 2,906,700 | 1,451,500 |
| Income taxes - deferred | -1,931,100 | -660,900 | -365,300 | -166,400 | -229,700 |
| Accounts receivable | 330,200 | -358,800 | -184,600 | -220,600 | 132,400 |
| Other Working Capital | -1,077,500 | 2,102,900 | 1,833,100 | -337,700 | -152,200 |
| Other Operating Activity | 938,600 | 5,211,100 | 4,730,000 | 4,624,500 | 2,439,300 |
| Operating Cash Flow | $116,500 | $7,238,700 | $5,568,400 | $2,644,300 | $1,234,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,569,600 | N/A | N/A | N/A |
| PPE Investments | -58,300 | -351,500 | -234,800 | -134,600 | -47,600 |
| Net Acquisitions | N/A | -80,600 | -80,600 | -80,600 | -80,600 |
| Purchase Of Investment | -5,000 | -3,938,000 | -3,738,000 | -738,200 | -538,200 |
| Sale Of Investment | N/A | N/A | 1,466,700 | N/A | N/A |
| Purchase Sale Intangibles | -57,600 | -58,300 | -46,000 | -46,000 | -7,500 |
| Other Investing Activity | 1,742,400 | -58,300 | -46,000 | 1,416,000 | 561,600 |
| Investing Cash Flow | $1,679,100 | $-2,858,800 | $-2,632,700 | $462,600 | $-104,800 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 11,900 | 3,300 | 3,300 | N/A |
| Debt Repayment | -3,031,800 | -1,044,900 | -1,044,900 | -1,039,100 | -159,400 |
| Common Stock Issued | 64,400 | 91,200 | 45,000 | 23,600 | 9,700 |
| Common Stock Repurchased | -54,700 | -840,600 | -834,300 | -833,500 | -829,200 |
| Dividend Paid | -243,500 | -974,400 | -731,400 | -488,800 | -246,100 |
| Other Financing Activity | -2,800 | -9,300 | -6,300 | -4,100 | -2,000 |
| Financing Cash Flow | $-3,268,400 | $-2,766,100 | $-2,568,600 | $-2,338,600 | $-1,227,000 |
| Exchange Rate Effect | -31,000 | 9,100 | -10,000 | 2,700 | 5,900 |
| Beginning Cash Position | 2,503,300 | 880,400 | 880,400 | 880,400 | 880,400 |
| End Cash Position | 999,500 | 2,503,300 | 1,237,500 | 1,651,400 | 788,500 |
| Net Cash Flow | $-1,503,800 | $1,622,900 | $357,100 | $771,000 | $-91,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 116,500 | 7,238,700 | 5,568,400 | 2,644,300 | 1,234,000 |
| Capital Expenditure | -60,400 | -375,200 | -253,300 | -152,300 | -64,800 |
| Free Cash Flow | 56,100 | 6,863,500 | 5,315,100 | 2,492,000 | 1,169,200 |